Antineoplastic agents. 548. Synthesis of iodo- and diiodocombstatin phosphate prodrugs

Journal of Natural Products

Volumn 75, Issue 3, 2012, Pages 385-393

  Pettit, George R ^a   Rosenberg, Heidi J ^a   Dixon, Rachel ^a   Knight, John C ^a   Hamel, Ernest ^b   Chapuis, Jean Charles ^a   Pettit, Robin K ^a   Hogan, Fiona ^a   Sumner, Brandy ^a   Ain, Kenneth B ^c   Trickey Platt, Brindi ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 IODO 4,4',5 TRIMETHOXY 3' HYDROXYSTILBENE; 3,5 DIIODO 4,4, DIMETHOXY 3' HYDROXYSTILBENE; ANTINEOPLASTIC AGENT; DIIODOCOMBSTATIN PHOSPHATE DERIVATIVE; IODOCOMBSTATIN PHOSPHATE DERIVATIVE; POTASSIUM 3,5 DIIODO 4,4' DIMETHOXYSTILBENE 3' O PHOSPHATE; PRODRUG; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; STRUCTURE ANALYSIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CHILD; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROCARBONS, IODINATED; MALE; MICE; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; ORGANOPHOSPHORUS COMPOUNDS; PRODRUGS; STILBENES;

MURINAE;

EID: 84859054664     PISSN: 01633864     EISSN: 15206025     Source Type: Journal    
DOI: 10.1021/np200797x     Document Type: Article

References (55)

1. For series part 547, consult: Suggitt, M.; Swaine, D. J.; Pettit, G. R.; Bibby, M. C. Clin. Cancer Res. 2004, 10, 6677-6685
2. For the most recent series part 592 refer to: Pettit, G. R.; Hogan, F.; Toms, S. J. Nat. Prod. 2011, 74, 962-968
3. Rustin, G. J.; Shreeves, G.; Nathan, P. D.; Gaya, A.; Ganesan, T. S.; Wang, D.; Boxall, J.; Poupard, L.; Chaplin, D. J.; Stratford, M. R. L.; Balkissoon, J.; Zweifel, M. Br. J. Cancer 2010, 102, 1355-1360
4. Mooney, C. J.; Nagaiah, G.; Fu, P.; Wasman, J. K.; Cooney, M. M.; Savvides, P.; Bokai, J. A.; Dowlati, A.; Wang, D.; Agarwala, S. S.; Flick, S. M.; Hartman, P. H.; Ortiz, J. D.; Laverlu, P. N.; Remick, S. C. Thyroid 2009, 19, 233-240
5. Siemann, D. W.; Chaplin, D. J.; Walicke, P. A. Expert Opin. Invest. Drugs 2009, 18, 189-197
6. Pinney, K. G.; Pettit, G. R.; Trawick, M. L.; Jelinek, C.; Chaplin, D. J. In Anticancer Agents from Natural Products, 2 nd ed.; Cragg, G. M.; Kingston, D. G. I.; Newman, D. J., Eds.; Taylor and Francis: Boca Raton, FL, 2011.
7. Marrelli, M.; Conforti, F.; Statti, G. A.; Cachet, X.; Michel, S.; Tillequin, F.; Menichini, F. Curr. Med. Chem. 2011, 18, 3035-3081
8. Zhang, C.; Wu, R.; Zhu, H.; Hu, Y.-z.; Jiang, H.; Lin, N.-m.; He, Q.-j.; Yang, B. Cancer Lett. 2011, 302, 11-19
9. Pettit, G. R.; Thornhill, A.; Melody, N.; Knight, J. C. J. Nat. Prod. 2009, 72, 380-388
10. Kanthou, C.; Tozer, G. M. Int. J. Exp. Pathol. 2009, 90, 284-294
11. Samarin, J.; Rehm, M.; Krueger, B.; Waschke, J.; Goppelt-Struebe, M. Mol. Cancer Res. 2009, 7, 180-188
12. Beale, T. M.; Myers, R. M.; Shearman, J. W.; Charnock-Jones, D. S.; Brenton, J. D.; Gergely, F. V.; Ley, S. V. Med. Chem. Commun. 2010, 1, 202-208
13. Schobert, R.; Biersack, B.; Dietrich, A.; Effenberger, K.; Knauer, S.; Mueller, T. J. Med. Chem. 2010, 53, 6595-6602
14. Coccetti, P.; Montano, G.; Lombardo, A.; Tripodi, F.; Orsini, F.; Pagliarin, R. Bioorg. Med. Chem. Lett. 2010, 20, 2780-2784
15. Pettit, G. R.; Minardi, M. D.; Hogan, F.; Price, P. M. J. Nat. Prod. 2010, 73, 399-403
16. Mazué, F.; Colin, D.; Gobbo, J.; Wagner, M.; Rescifina, A.; Spatafora, C.; Fasseur, D.; Delmas, D.; Meunier, P.; Tringali, C.; Latruffe, N. Eur. J. Med. Chem. 2010, 45, 2972-2980
17. Lee, L.; Robb, L. M.; Lee, M.; Davis, R.; Mackay, H.; Chavda, S.; Babu, B.; O'Brien, E. L.; Risinger, A. L.; Mooberry, S. L.; Lee, M. J. Med. Chem. 2010, 53, 325-334
18. Pettit, R. K.; Pettit, G. R.; Hamel, E.; Hogan, F.; Moser, B. R.; Wolf, S.; Pon, S.; Chapuis, J.-C.; Schmidt, J. M. Bioorg. Med. Chem. 2009, 17, 6606-6612
19. McNulty, J.; Das, P. Eur. J. Org. Chem. 2009, 4031-4035
20. Pettit, G. R.; Melody, N.; Thornhill, A.; Knight, J. C.; Groy, T. L.; Herald, C. L. J. Nat. Prod. 2009, 72, 1637-1642
21. Brown, R. T.; Murrell, V. L.; McMordie, A.; Sriram, M.; Pinney, K. G.; Sharma, S.; Chaplin, D. J. J. Label. Compd. Radiopharm. 2009, 52, 567-570
22. Messaoudi, S.; Tréguier, B.; Hamze, A.; Provot, O.; Peyrat, J.-F.; De Losada, J. R.; Liu, J.-M.; Bignon, J.; Wdzieczak-Bakala, J.; Thoret, S.; Dubois, J.; Brion, J.-D.; Alami, M. J. Med. Chem. 2009, 52, 4538-4542
23. Siegel, R.; Ward, E.; Brawley, O.; Jemal, A. CA Cancer J. Clin. 2011, 61, 212-236
24. Nagaiah, G.; Hossain, A.; Mooney, C. J.; Parmentier, J.; Remick, S. C. J. Oncol. 2011, Article ID 542358.
25. Carling, T.; Udelsman, R. In DeVita, Hellman, and Rosenberg's Cancer Principles and Practice of Oncology, 8 th ed.; DeVita, V. T., Jr.; Lawrence, T. S.; Rosenberg, S. A., Eds.; Lippincott Williams and Wilkins: Philadelphia, PA, 2008; Vol. 2, pp 1663-1681.
26. Henderson, B. E.; Bernstein, L.; Ross, R. K. In Holland-Frei Cancer Medicine, 6 th ed.; Kufe, D. W.; Pollock, R. E.; Weichselbaum, R. R.; Bast, R. C.; Gansler, T. S.; Holland, J. F.; Frei, E., III, Eds.; B. C. Decker: Hamilton, ON, 2003; Chapter 18, p 286.
27. Sherman, S. I.; Gillenwater, A. M. In Holland-Frei Cancer Medicine, 6 th ed.; B. C. Decker: Hamilton, ON, 2003; Chapter 87, p 1259.
28. Haymart, M. R.; Banerjee, M.; Stewart, A. K.; Koenig, R. J.; Birkmeyer, J. D.; Griggs, J. J. JAMA, J. Am. Med. Assoc. 2011, 306, 721-728
29. Davies, L.; Welch, H. G. JAMA, J. Am. Med. Assoc. 2006, 295, 2164-2167
30. Combes, S.; Barbier, P.; Douillard, S.; McLeer-Florin, A.; Bourgarel-Rey, V.; Pierson, J.-T.; Federov, A. Y.; Finet, J.-P.; Boutonnat, J.; Peyrot, V. J. Med. Chem. 2011, 54, 3153-3162
31. West, C. M. L.; Price, P. Anti-Cancer Drugs 2004, 15, 179-187
32. Cooney, M. M.; Radivoyevitch, T.; Dowlati, A.; Overmoyer, B.; Levitan, N.; Robertson, K.; Levine, S. L.; DeCaro, K.; Buchter, C.; Taylor, A.; Stambler, B. S.; Remick, S. C. Clin. Cancer Res. 2004, 20, 96-100
33. Rustin, G. J. S.; Galbraith, S. M.; Anderson, H.; Stratford, M.; Folkes, L. K.; Sena, L.; Gumbrell, L.; Price, P. M. J. Clin. Oncol. 2003, 21, 2815-2822
34. Stevenson, J. P.; Rosen, M.; Sun, W.; Gallagher, M.; Haller, D. G.; Vaughn, D.; Giantonio, B.; Zimmer, R.; Petros, W. P.; Stratford, M.; Chaplin, D.; Young, S. L.; Schnall, M.; O'Dwyer, P. J. J. Clin. Oncol. 2003, 21, 4428-4438
35. Hall, J. J.; Sriram, M.; Strecker, T. E.; Tidmore, J. K.; Jelinek, C. J.; Kumar, G. D. K.; Hadimani, M. B.; Pettit, G. R.; Chaplin, D. J.; Trawick, M. L.; Pinney, K. G. Bioorg. Med. Chem. Lett. 2008, 18, 5146-5149
36. Pettit, G. R.; Minardi, M. D.; Rosenberg, H. J.; Hamel, E.; Bibby, M. C.; Martin, S. W.; Jung, M. K.; Pettit, R. K.; Cuthbertson, T. J.; Chapuis, J.-C. J. Nat. Prod. 2005, 68, 1450-1458
37. Pettit, G. R.; Rosenberg, H. J.; Minardi, M. D. PCT Int. Patent, WO 2006036743 A2 20060406, 2006.
38. Pettit, G. R.; Minardi, M. D. U.S. Patent 20050176688 A1 20050811, 2005.
39. Lawrence, N. J.; Hepworth, L. A.; Rennison, D.; McGown, A. T.; Hadfield, J. A. J. Fluorine Chem. 2003, 123, 101-108
40. Pettit, G. R.; Lippert, J. W., III. Anti-Cancer Drug Des. 2000, 15, 203-216
41. Pettit, G. R.; Rhodes, M. R. Anti-Cancer Drug Des. 1998, 13, 183-191
42. Pettit, G. R.; Minardi, M. D.; Boyd, M. R.; Pettit, R. K. Anti-Cancer Drug Des. 2000, 15, 397-404
43. Schweppe, R. E.; Klopper, J. P.; Korch, C.; Pugazhenthi, U.; Benezra, M.; Knauf, J. A.; Fagin, J. A.; Marlow, L. A.; Copland, J. A.; Smallridge, R. C.; Haugen, B. R. J. Clin. Endocrinol. Metab. 2008, 93, 4331-4341
44. Taraboletti, G.; Giavazzi, R. Eur. J. Cancer 2004, 40, 881-889
45. Hori, K.; Saito, S.; Kubota, K. Br. J. Cancer 2002, 86, 1604-1614
46. Verdier-Pinard, P.; Lai, J.-Y.; Yoo, H.-D.; Yu, J.; Marquez, B.; Nagle, D. G.; Nambu, M.; White, J. D.; Falck, J. R.; Gerwick, W. H.; Day, B. W.; Hamel, E. Mol. Pharmacol. 1998, 53, 62-76
47. Kang, G.-J.; Getahun, Z.; Muzaffar, A.; Brossi, A.; Hamel, E. J. Biol. Chem. 1990, 265, 10255-10259
48. Pettit, G. R.; Rhodes, M. R.; Herald, D. L.; Chaplin, D. J.; Stratford, M.; Hamel, E.; Pettit, R. K.; Chapuis, J.-C.; Oliva, D. Anti-Cancer Drug Des. 1998, 13, 981-993
49. Wilkinson, J. H. J. Chem. Soc. 1949, 2370-2371
50. Hamel, E. Cell Biochem. Biophys. 2003, 38, 1-21
51. Monks, A.; Scudiero, D.; Skehan, P.; Shoemaker, R.; Paull, K.; Vistica, D.; Hose, C.; Langley, J.; Cronise, P.; Vaigro-Wolff, A.; Gray-Goodrich, M.; Campbell, H.; Mayo, J.; Boyd, M. J. Natl. Cancer Inst. 1991, 83, 757-766
52. Suffness, M.; Douros, J. In Methods in Cancer Research; DeVita, V. T., Jr.; Bush, H., Eds.; Academic: New York, 1979; Vol. 16, pp 73-126.
53. Developmental Therapeutics Program NCI/NIH, Discovery Services, Angiogenesis Resource Center (http://dtp.nci.nih.gov/aa-resources/aa-index.html) , 2009.
54. NCCLS. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard, 5 th ed.; NCCLS document M7-A5 [ISBN 1-56238-394-9 ]; NCCLS: Wayne, PA, 2000.
55. NCCLS. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard, 2 nd ed.; NCCLS document M27-A2 [ISBN 1-56238-469-4 ]; NCCLS: Wayne, PA, 2002.